• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SHIRAKAWA OLYMPUS CO., LTD. EVIS EXERA II ULTRASONIC BRONCHOFIBERVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SHIRAKAWA OLYMPUS CO., LTD. EVIS EXERA II ULTRASONIC BRONCHOFIBERVIDEOSCOPE Back to Search Results
Model Number BF-UC180F
Medical Device Problem Code Device Reprocessing Problem (1091)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/10/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The endoscopy support specialist (ess) provided a reprocessing in-service/reprocessing training to the user facility staff.The ess provided the user facility staff reprocessing training materials for their reference.The evaluation of the event is ongoing.Should additional relevant information become available, a supplemental report will be submitted.
 
Event or Problem Description
Olympus was informed that during an onsite visit, the user facility staff used a 10ml syringe instead of a 30 ml syringe to reprocess a bronchofibervideoscope.No patient infections or injuries reported.
 
Additional Manufacturer Narrative
This supplemental report is being submitted to provide the results of the legal manufacturer's final investigation.Corrected fields: g2 company representative should be deselected and health care professional should be selected on the initial medwatch.H4 of the initial report was corrected, please see h4 for further details.A review of the device history record found no deviations that could have caused or contributed to the reported issue.It has been over 12 years since the subject device was manufactured.Based on the results of the investigation, and since the device was not returned for evaluation, the root cause could not be conclusively identified.However, it is likely that the customer used a 10ml syringe for flushing the balloon channel instead of 30ml syringe per the instructions for use.The instructions for use states the prevention methods associated with the event in instructions evis exera ii ultrasonic bronchofibervideoscope olympus bf type uc180f chapter 7 cleaning, disinfection, and sterilization procedures.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS EXERA II ULTRASONIC BRONCHOFIBERVIDEOSCOPE
Common Device Name
ULTRASONIC BRONCHOFIBERVIDEOSCOPE
Manufacturer (Section D)
SHIRAKAWA OLYMPUS CO., LTD.
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima 961-8 061
JA  961-8061
Manufacturer (Section G)
SHIRAKAWA OLYMPUS CO., LTD.
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key19560720
Report Number3002808148-2024-05545
Device Sequence Number4850591
Product Code PSV
UDI-Device Identifier04953170243233
UDI-Public04953170243233
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
K070983
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Administrator/Supervisor
Type of Report Initial,Followup
Report Date (Section B) 07/11/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberBF-UC180F
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/10/2024
Supplement Date Received by Manufacturer07/05/2024
Initial Report FDA Received Date06/18/2024
Supplement Report FDA Received Date07/11/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured06/19/2012
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Reuse
Patient Sequence Number1
Patient SexUnknown
-
-